Ting Xu
Net worth: 367 M $ as of 31/05/2026
Net worth: 367 M $ as of 31/05/2026
Founder of Alphamab Oncology and Suzhou Alphamab Co. Ltd., Ting Xu currently is Chairman, President & Chief Executive Officer at Suzhou Alphamab Co. Ltd., Director & General Manager at Jiangsu Alphamab Biopharmaceuticals Co. Ltd (a subsidiary of Suzhou Alphamab Co. Ltd.), Chairman & Chief Executive Officer for Alphamab Oncology and Chairman for Suzhou SmartNuclide Biopharmaceutical Co. Ltd. He is also on the board of Suzhou Bionovogene Biotech Co. Ltd., Shanghai Kangjing Bioscience Co. Ltd. and Suzhou Oncoimmune Co. Ltd. In the past Ting Xu occupied the position of Senior Scientist at Biogen Idec, Inc. (North Carolina). He received an undergraduate degree from the University of Nanjing and a doctorate and a graduate degree from Chinese Academy of Sciences.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ALPHAMAB ONCOLOGY 32.4% | 19/11/2025 | 315,675,016 ( 32.4% ) | 367 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| ALPHAMAB ONCOLOGY | Chief Executive Officer | 01/10/2018 |
Suzhou Alphamab Co., Ltd.
Suzhou Alphamab Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology compnay | Founder | 01/01/2008 |
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Jiangsu Alphamab Biopharmaceuticals Co., Ltd Pharmaceuticals: MajorHealth Technology Manufactures and distributes therapeutics for cancer treatment | Chief Executive Officer | 01/01/2015 |
Suzhou SmartNuclide Biopharmaceutical Co., Ltd.
Suzhou SmartNuclide Biopharmaceutical Co., Ltd. BiotechnologyHealth Technology Develops and manufactures radiopharmaceuticals | Founder | 01/01/2015 |
Suzhou Bionovogene Biotech Co. Ltd. | Director/Board Member | - |
Shanghai Kangjing Bioscience Co. Ltd. | Director/Board Member | - |
Suzhou Oncoimmune Co. Ltd. | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 01/01/2010 |
Suzhou PANOMIX Biomedical Tech Co., Ltd.
Suzhou PANOMIX Biomedical Tech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Provides metabolomics testing and analysis services | Chairman | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
Nanjing University
Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chinese Academy of Sciences
Chinese Academy of Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Suzhou Alphamab Co., Ltd.
Suzhou Alphamab Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology compnay | Commercial Services |
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Jiangsu Alphamab Biopharmaceuticals Co., Ltd Pharmaceuticals: MajorHealth Technology Manufactures and distributes therapeutics for cancer treatment | Health Technology |
Alphamab Oncology
Alphamab Oncology BiotechnologyHealth Technology Operates as biopharmaceutical company which engages in development manufacturing and commercialization of therapeutics for cancer treatment | Health Technology |
Suzhou SmartNuclide Biopharmaceutical Co., Ltd.
Suzhou SmartNuclide Biopharmaceutical Co., Ltd. BiotechnologyHealth Technology Develops and manufactures radiopharmaceuticals | Health Technology |
Suzhou Bionovogene Biotech Co. Ltd. | |
Shanghai Kangjing Bioscience Co. Ltd. | |
Suzhou Oncoimmune Co. Ltd. | |
Suzhou PANOMIX Biomedical Tech Co., Ltd.
Suzhou PANOMIX Biomedical Tech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Provides metabolomics testing and analysis services | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions